This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
According to the Australian Bureau of Statistics, the number of people aged 65 years or older is expected to exceed the number of children aged 14 and below by as soon as 2030. of respondents who received Medical Cannabis treatment reported improvement in their condition and significant reductions to pain levels.
On June 18, 2021, Palo Santo , the leading psychedelic investment fund helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions, issued the following statement regarding atai Life Sciences’ (“atai” or “Company”) ( NASDAQ: ATAI ) initial public offering. . trillion by 2030.
According to the Lancet Commission, mental health disorders are on the rise in every country worldwide, and the resulting lost productivity will cost the global economy $16 trillion by 2030. Yet, despite nearly two billion people with mental illness each year, these conditions are routinely misdiagnosed and inadequately treated.
Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. But, of course, the growth in the market will depend mainly on accurately diagnosing patients with certain mental illnesses and successfully treating those conditions with psychedelics.
We are excited to be developing and bringing to market treatments addressing cluster headaches, neuropathic pain and range of mental health conditions, including depression, anxiety and PTSD, and related disorders.”. billion in 2019 and projected to reach near US$25 billion by 2030. billion industry by 2027.
June 18, 2021 (Chicago) — Palo Santo , the leading psychedelic investment fund helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions, issued the following statement regarding atai Life Sciences ’ (“atai” or “Company”) ( NASDAQ: ATAI ) initial public offering.
have a long history rooted in protecting workers from dangerous and unfair work conditions. To address these issues, groups of workers started organizing into unions, creating a united front to demand better conditions, wages, and benefits. Background on Labor Unions in the U.S. Labor unions in the U.S. million U.S.
DUBLIN–(BUSINESS WIRE)–The “Global Cannabis Market- Market Size & Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. million by 2030 at a CAGR of 23.9%, 2021-2030. Growing Adoption of Medical Cannabis for the Treatment of Chronic Compounds. Restraints.
In a June, 2020 interview, a Swiss drug policy expert told Marijuana Business Daily that the scientific process behind the pilot program is expected to last five years, and that if everything goes as planned, the matter of full recreational cannabis legalization for adults could be debated by 2030. How do the Swiss generally view marijuana?
More investment is needed for research into the harm that the non-medical use of cannabis poses to health and to better define the range of health conditions for which cannabis products may be an effective treatment. Drug Use Rising, but Science-Based Treatment More Available. The Dark Web.
Deletion Syndrome – Global Market Insights, Epidemiology and Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. deletion syndrome in the 7MM covering United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2018 to 2030. Country-Wise Epidemiology.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content